[Consumption coagulopathies].
D062365:Aminobenzoates / Q000627:therapeutic use; D000614:Aminocaproates / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology; D001803:Blood Transfusion; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008744:Methylamines / Q000627:therapeutic use; D013300:Streptokinase / Q000494:pharmacology; D013916:Thrombelastography; D013927:Thrombosis / Q000209:etiology
D062365:Aminobenzoates; D000614:Aminocaproates; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D005340:Fibrinogen; D006493:Heparin; D013300:Streptokinase
La coagulopatia da consumo.